CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2025-2032³â)
CBD Nutraceuticals Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
Persistence Market Research´Â ÃÖ±Ù ¼¼°è CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ º¸°í¼¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ º¸°í¼´Â ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, µ¿Çâ, ±âȸ ¹× °úÁ¦¸¦ Æ÷ÇÔÇÑ ÁÖ¿ä ½ÃÀå ¿ªÇÐÀ» öÀúÈ÷ Æò°¡ÇÏ°í ½ÃÀå ±¸Á¶¿¡ ´ëÇÑ ½ÉÃþÀûÀÎ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ º¸°í¼´Â 2025³âºÎÅÍ 2032³â±îÁö ¼¼°è CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå ¿¹Ãø ¼ºÀå ±ËÀûÀ» °³°ýÇÏ´Â µ¶Á¡ÀûÀÎ µ¥ÀÌÅÍ¿Í Åë°è¸¦ Á¦°øÇÕ´Ï´Ù.
ÁÖ¿ä ÀλçÀÌÆ®
- CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå ±Ô¸ð(2025³â) : 103¾ï 8,000¸¸ ´Þ·¯
- ½ÃÀå ±Ô¸ð ¿¹Ãø(±Ý¾× ±âÁØ, 2032³â) : 233¾ï 6,000¸¸ ´Þ·¯
- ¼¼°è ½ÃÀå ¼ºÀå·ü(CAGR, 2025-2032³â) : 12.3%
CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå : ºÐ¼® ¹üÀ§
CBD ´ºÆ®¶ó½´Æ¼ÄÃÀº ÅëÁõ ¿ÏÈ, ½ºÆ®·¹½º °ü¸®, ÀÎÁö ±â´É °³¼± µî ÀáÀçÀûÀÎ °Ç° È¿°ú·Î ÀÎÇØ ³Î¸® Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °Ç°º¸Á¶½ÄǰÀº ĸ½¶, ±¸¹Ì, ÆÃÅ©, µå¸µÅ©, ±â´É¼º ½Äǰ µî ´Ù¾çÇÑ ÇüÅ·ΠÆÇ¸ÅµÇ°í ÀÖ½À´Ï´Ù. CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀåÀº CBD(Cannabidiol)ÀÇ Ä¡·á È¿°ú¿¡ ´ëÇÑ ¼ÒºñÀÚ ÀÎ½Ä Áõ°¡, CBD ÇÔÀ¯ Á¦Ç°À» Áö¿øÇÏ´Â ±ÔÁ¦ °È, ½Ä¹°¼º À£ºù ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µîÀÌ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ½´ÆÛ¸¶ÄÏ, ¿Â¶óÀÎ ¼Ò¸ÅÁ¡, Àü¹®Á¡ µî ´Ù¾çÇÑ ÃÖÁ¾ »ç¿ëÀÚ¿¡°Ô ¼ºñ½º¸¦ Á¦°øÇϸç, ¼ÒºñÀÚ¿¡°Ô ´Ù¾çÇÑ °Ç° ¹× À£´Ï½º ¿ëµµÀÇ Á¦Ç° ¼±ÅñÇÀ» Á¦°øÇÕ´Ï´Ù.
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ:
¼¼°è CBD °Ç° º¸Á¶ ½Äǰ ½ÃÀåÀº õ¿¬ °Ç° º¸Á¶ ½Äǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ´Ù¾çÇÑ Áö¿ª¿¡¼ CBD Á¦Ç°ÀÇ ÇÕ¹ýÈ µî ¸î °¡Áö Áß¿äÇÑ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¸¸¼º ÅëÁõ, ºÒ¾È, ½Å°æ Àå¾Ö Ä¡·á¿¡ ´ëÇÑ CBDÀÇ È¿´É¿¡ ´ëÇÑ ¿¬±¸ Áõ°¡µµ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½Ä¹°¼º ¹× À¯±â³ó °Ç°±â´É½Äǰ¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ¼±È£µµ º¯Èµµ CBD ´ºÆ®¶ó½´Æ¼ÄÃÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. »ýü ÀÌ¿ë·üÀ» ³ôÀ̱â À§ÇÑ ¼ö¿ë¼º CBD ¹× ³ª³ë À¯È CBD¿Í °°Àº Çõ½ÅÀûÀÎ Á¦Ç° Á¦ÇüÀÇ ÃâÇöÀº °Ç° ÁöÇâÀûÀÎ ¼ÒºñÀÚµé »çÀÌ¿¡¼ Á¦Ç° äÅÃÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ:
À¯¸ÁÇÑ ¼ºÀå Àü¸Á¿¡µµ ºÒ±¸Çϰí, CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀåÀº ±ÔÁ¦ ºÒÈ®½Ç¼º, Á¦Ç° Ç¥ÁØÈ, CBDÀÇ ¾ÈÀü¼º¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ´Ù¾çÇÑ Àνİú °ü·ÃµÈ ¹®Á¦¿¡ Á÷¸éÇØ ÀÖÀ¸¸ç, CBD ÇÔÀ¯ Á¦Ç°ÀÇ ÆÇ¸Å ¹× ¸¶ÄÉÆÃ¿¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦´Â Á¦Á¶¾÷ü¿¡°Ô ÄÄÇöóÀ̾𽺠¹®Á¦¸¦ ¾ß±âÇÏ°í Æ¯Á¤ Áö¿ªÀ¸·Î ½ÃÀå ÁøÀÔ¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. ƯÁ¤ Áö¿ª¿¡¼ ½ÃÀå ÁøÀÔ¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ¶ÇÇÑ, ÅëÀÏµÈ Ç°Áú ±âÁØÀÌ ¾ø°í, ǰÁúÀÌ ³·°Å³ª À߸øµÈ ¶óº§ÀÌ ºÎÂøµÈ Á¦Ç°ÀÌ ½ÃÀå¿¡ Á¸ÀçÇÏ¸é ¼ÒºñÀÚµé »çÀÌ¿¡ ½Å·Ú ¹®Á¦°¡ ¹ß»ýÇÕ´Ï´Ù. ¶ÇÇÑ, ÇÁ¸®¹Ì¾ö CBD ´ºÆ®¶ó½´Æ¼ÄÃÀº °í°¡À̱⠶§¹®¿¡ ƯÈ÷ °¡°Ý¿¡ ¹Î°¨ÇÑ ½ÃÀå¿¡¼´Â °¡°Ý ´ëºñ È¿¿ë¼ºÀÌ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù.
½ÃÀå ±âȸ:
CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀåÀº À£ºù¿¡ ÃÊÁ¡À» ¸ÂÃá °Ç°±â´É½Äǰ¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼±È£µµ Áõ°¡, Á¦Ç° À¯ÅëÀ» À§ÇÑ ÀüÀÚ»ó°Å·¡ ä³ÎÀÇ È®´ë, ÁÖ·ù À½·á ¹× ½Äǰ¿¡ CBD°¡ Á¡Á¡ ´õ ¸¹ÀÌ µµÀÔµÇ¸é¼ Å« ¼ºÀå ±âȸ¸¦ º¸À̰í ÀÖÀ¸¸ç, CBD°¡ ÇÔÀ¯µÈ ±â´É¼º À½·á ¹× °³ÀÎ ¸ÂÃãÇü CBD ¿µ¾ç °Ç°º¸Á¶½ÄǰÀ» Æ÷ÇÔÇÑ »õ·Î¿î CBD Àü´Þ ½Ã½ºÅÛ ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ È®´ë´Â ½ÃÀå È®´ë¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ÀÓ»ó½ÃÇè ¹× Á¦Ç° Çõ½ÅÀ» À§ÇÑ CBD Á¦Á¶¾÷ü¿Í Á¦¾àȸ»çÀÇ ÆÄÆ®³Ê½ÊÀº »õ·Î¿î ½ÃÀåÀÇ ±æÀ» ¿¾î Àå±âÀûÀ¸·Î Áö¼Ó °¡´ÉÇÑ ¼ºÀåÀ» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.
º» º¸°í¼¿¡¼ ´äº¯À» ¾òÀ» ¼ö ÀÖ´Â ÁÖ¿ä Áú¹®
- CBD °Ç° º¸Á¶ ½Äǰ ½ÃÀåÀÇ ¼¼°è ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?
- ¾î¶² Á¦Ç° À¯Çü°ú À¯Åë ä³ÎÀÌ ½ÃÀå È®´ë¿¡ ±â¿©Çϴ°¡?
- ±ÔÁ¦ »óȲÀº CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå °æÀï ±¸µµ¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¡°í Àִ°¡?
- ¾÷°èÀÇ ÁÖ¿ä ±â¾÷Àº ´©±¸À̸ç, ½ÃÀå¿¡¼ÀÇ ÀÔÁö¸¦ °ÈÇϱâ À§ÇØ ¾î¶² Àü·«À» ÃëÇϰí Àִ°¡?
- ¼¼°è CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀåÀÇ »õ·Î¿î Æ®·»µå¿Í ¹Ì·¡ Àü¸ÁÀº?
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå ½ÃÀå °³¿ä
- ½ÃÀå ¹üÀ§¿Í Á¤ÀÇ
- ½ÃÀå ¿ªÇÐ
- ¼ºÀå ÃËÁø¿äÀÎ
- ¼ºÀå ¾ïÁ¦¿äÀÎ
- ±âȸ
- ÁÖ¿ä µ¿Çâ
- °Å½Ã°æÁ¦ ¿äÀÎ
- ¼¼°èÀÇ ºÎ¹®º° Àü¸Á
- ¼¼°èÀÇ GDP ¼ºÀå Àü¸Á
- COVID-19ÀÇ ¿µÇ⠺м®
- ¿¹Ãø ¿äÀÎ : °ü·Ã¼º°ú ¿µÇâ
Á¦3Àå ºÎ°¡°¡Ä¡ ÅëÂû
- Á¦Ç° äÅà ºÐ¼®
- ±ÔÁ¦ »óȲ
- ¹ë·ùüÀÎ ºÐ¼®
- PESTLE ºÐ¼®
- PorterÀÇ Five Forces ºÐ¼®
Á¦4Àå ¼¼°èÀÇ CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå Àü¸Á
- ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
- ½ÃÀå ±Ô¸ð¿Í Àü³â´ëºñ ¼ºÀå·ü(10¾ï ´Þ·¯)
- Àý´ëÀû ¸ÅÃâ ±âȸ
- ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø(10¾ï ´Þ·¯)
- °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼®(10¾ï ´Þ·¯, 2019-2024³â)
- ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø(10¾ï ´Þ·¯, 2025-2032³â)
- ¼¼°èÀÇ CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå Àü¸Á : Á¦Ç°º°
- ¼·Ð/ÁÖ¿ä Á¶»ç °á°ú
- °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : À¯Çüº°(10¾ï ´Þ·¯, 2019-2024³â)
- ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : À¯Çüº°(10¾ï ´Þ·¯, 2025-2032³â)
- CBD ±¸¹Ì
- CBD ƾŰ
- ĸ½¶ ¹× ¼ÒÇÁÆ®Á©
- ¿¬°í ¹× ¹ã
- ±âŸ
- ½ÃÀå ¸Å·Â ºÐ¼® : Á¦Ç°º°
- ¼¼°èÀÇ CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå Àü¸Á : Çüź°
- ¼·Ð/ÁÖ¿ä Á¶»ç °á°ú
- °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : Çüź°(10¾ï ´Þ·¯, 2019-2024³â)
- ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : Çüź°(10¾ï ´Þ·¯, 2025-2032³â)
- ½ÃÀå ¸Å·Â ºÐ¼® : Çüź°
- ¼¼°èÀÇ CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå Àü¸Á : ¿ëµµº°
- ¼·Ð/ÁÖ¿ä Á¶»ç °á°ú
- °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : ¿ëµµº°(10¾ï ´Þ·¯, 2019-2024³â)
- ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : ¿ëµµº°(10¾ï ´Þ·¯, 2025-2032³â)
- ÅëÁõ °ü¸®
- ¼ö¸é Áö¿ø
- ÇǺΠ°Ç° ¹× ¹Ì¿ë
- ¿îµ¿ º¸ÃæÁ¦
- ±âŸ
- ½ÃÀå ¸Å·Â ºÐ¼® : ¿ëµµº°
- ¼¼°èÀÇ CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå Àü¸Á : À¯Åë ä³Îº°
- ¼·Ð/ÁÖ¿ä Á¶»ç °á°ú
- °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : À¯Åë ä³Îº°(10¾ï ´Þ·¯, 2019-2024³â)
- ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : À¯Åë ä³Îº°(10¾ï ´Þ·¯, 2025-2032³â)
- º´¿ø ¾à±¹
- ¼Ò¸Å ¾à±¹
- ¿Â¶óÀÎ ¾à±¹
- ½ÃÀå ¸Å·Â ºÐ¼® : À¯Åë ä³Îº°
Á¦5Àå ¼¼°èÀÇ CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå Àü¸Á : Áö¿ªº°
- ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
- °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : Áö¿ªº°(10¾ï ´Þ·¯, 2019-2024³â)
- ÇöÀç ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : Áö¿ªº°(10¾ï ´Þ·¯, 2025-2032³â)
- ºÏ¹Ì
- À¯·´
- µ¿¾Æ½Ã¾Æ
- ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾Æ
- ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- ½ÃÀå ¸Å·Â ºÐ¼® : Áö¿ª
Á¦6Àå ºÏ¹ÌÀÇ CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå Àü¸Á
Á¦7Àå À¯·´ÀÇ CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå Àü¸Á
Á¦8Àå µ¿¾Æ½Ã¾ÆÀÇ CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå Àü¸Á
Á¦9Àå ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾ÆÀÇ CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå Àü¸Á
Á¦10Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå Àü¸Á
Á¦11Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ CBD ´ºÆ®¶ó½´Æ¼Äà ½ÃÀå Àü¸Á
Á¦12Àå °æÀï ±¸µµ
- ½ÃÀå Á¡À¯À² ºÐ¼®(2025³â)
- ½ÃÀå ±¸Á¶
- °æÀï °µµ ¸Ê : ½ÃÀ庰
- °æÀï ´ë½Ãº¸µå
- ±â¾÷ °³¿ä(»ó¼¼ : °³¿ä, À繫, Àü·«, ÃÖ±Ù µ¿Çâ)
- GVB Biopharma
- Brains
- NOW
- Dr. CBD Company Limited
- dsm-firmenich
- Charlotte's Web, Inc.
- Elixinol
- Medical Marijuana, Inc.
- CV Sciences, Inc.
- Irwin Naturals
- Diamond CBD
- Foria Wellness(Eden Partners LLC)
- Medterra CBD
- Green Roads
- Isodiol International Inc
- Garden of Life
- Bluebird Botanicals(Gaia Botanicals, LLC)
- Endoca
- One Farm
- Treadwell Farms
- CBD Worx
- USA Medical
- NuLeaf Naturals, LLC
- EarlyBird CBD
Á¦13Àå ºÎ·Ï
- ºÐ¼® ¹æ¹ý
- ºÐ¼® ÀüÁ¦Á¶°Ç
- µÎÀÚ¾î ¹× ¾à¾î
LSH
Persistence Market Research has recently released a comprehensive report on the worldwide market for CBD nutraceuticals. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global CBD nutraceuticals market from 2025 to 2032.
Key Insights:
- CBD Nutraceuticals Market Size (2025E):US$ 10.38 Bn
- Projected Market Value (2032F): US$ 23.36 Bn
- Global Market Growth Rate (CAGR 2025 to 2032): 12.3%
CBD Nutraceuticals Market - Report Scope:
CBD nutraceuticals are gaining widespread popularity due to their potential health benefits, including pain relief, stress management, and improved cognitive function. These nutraceuticals are available in various forms such as capsules, gummies, tinctures, beverages, and functional foods. The market is driven by increasing consumer awareness regarding the therapeutic properties of cannabidiol (CBD), regulatory advancements supporting CBD-infused products, and growing demand for plant-based wellness solutions. The CBD nutraceuticals market serves a wide range of end-users, including pharmacies, online retailers, supermarkets, and specialty stores, providing consumers with diverse product options for health and wellness applications.
Market Growth Drivers:
The global CBD nutraceuticals market is propelled by several key factors, including the rising demand for natural health supplements and the increasing legalization of CBD products across various regions. Growing research into CBD's efficacy in treating chronic pain, anxiety, and neurological disorders is also fostering market growth. Additionally, shifting consumer preferences towards plant-based and organic dietary supplements contribute to the expansion of CBD nutraceuticals. The emergence of innovative product formulations, such as water-soluble CBD and nano-emulsified CBD for enhanced bioavailability, is further driving product adoption among health-conscious consumers.
Market Restraints:
Despite promising growth prospects, the CBD nutraceuticals market faces challenges related to regulatory uncertainties, product standardization, and varying consumer perceptions about CBD safety. Stringent regulations governing the sale and marketing of CBD-infused products pose compliance challenges for manufacturers, impacting market entry in certain regions. Additionally, the lack of uniform quality standards and the presence of low-quality or mislabeled products in the market create trust issues among consumers. Moreover, the high cost of premium CBD nutraceuticals may limit their affordability, particularly in price-sensitive markets.
Market Opportunities:
The CBD nutraceuticals market presents significant growth opportunities driven by increasing consumer inclination toward wellness-focused dietary supplements, the expansion of e-commerce channels for product distribution, and the rising incorporation of CBD in mainstream food and beverage products. Growing investments in research and development for novel CBD delivery systems, including CBD-infused functional beverages and personalized CBD nutraceuticals, are expected to fuel market expansion. Furthermore, partnerships between CBD manufacturers and pharmaceutical companies for clinical trials and product innovations can unlock new market avenues, ensuring sustainable growth in the long term.
Key Questions Answered in the Report:
- What are the primary factors driving the growth of the CBD nutraceuticals market globally?
- Which product types and distribution channels are contributing to market expansion?
- How are regulatory developments influencing the competitive landscape of the CBD nutraceuticals market?
- Who are the key players in the industry, and what strategies are they employing to strengthen their market presence?
- What are the emerging trends and future prospects in the global CBD nutraceuticals market?
Competitive Intelligence and Business Strategy:
Leading players in the global CBD nutraceuticals market, including Charlotte's Web Holdings, CV Sciences, Inc., Medterra CBD, and Elixinol Global Limited, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced CBD formulations, including water-soluble CBD, broad-spectrum extracts, and CBD-infused functional foods, catering to diverse consumer preferences. Partnerships with retail chains, online platforms, and healthcare professionals facilitate wider market access and enhance consumer trust. Additionally, emphasis on consumer education, transparency in labeling, and compliance with evolving regulations strengthens brand positioning and market credibility.
Key Companies Profiled:
- Charlotte's Web Holdings
- CV Sciences, Inc.
- Medterra CBD
- Elixinol Global Limited
- Green Roads
- Canopy Growth Corporation
- Isodiol International Inc.
- Aurora Cannabis Inc.
- Bluebird Botanicals
- Endoca
CBD Nutraceuticals Market Segmentation
By Product
- CBD Gummies
- CBD Tinctures
- Capsules and Softgels
- Salves and Balms
By Form
By Application
- Pain Management
- Sleep Support
- Skin Health and Beauty
- Workout Supplements
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region
- North America
- Europe
- East Asia
- South Asia and Oceania
- Middle East and Africa
- Latin America
Table of Contents
1. Executive Summary
- 1.1. Global CBD Nutraceuticals Market Snapshot, 2025 and 2032
- 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
- 1.3. Key Market Trends
- 1.4. Future Market Projections
- 1.5. Premium Market Insights
- 1.6. Industry Developments and Key Market Events
- 1.7. PMR Analysis and Recommendations
2. Market Overview
- 2.1. Market Scope and Definition
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Key Trends
- 2.3. Macro-Economic Factors
- 2.3.1. Global Sectorial Outlook
- 2.3.2. Global GDP Growth Outlook
- 2.4. COVID-19 Impact Analysis
- 2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
- 3.1. Product Adoption Analysis
- 3.2. Regulatory Landscape
- 3.3. Value Chain Analysis
- 3.4. PESTLE Analysis
- 3.5. Porter's Five Force Analysis
4. Global CBD Nutraceuticals Market Outlook
- 4.1. Key Highlights
- 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
- 4.1.2. Absolute $ Opportunity
- 4.2. Market Size (US$ Bn) Analysis and Forecast
- 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
- 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
- 4.3. Global CBD Nutraceuticals Market Outlook: Product
- 4.3.1. Introduction / Key Findings
- 4.3.2. Historical Market Size (US$ Bn) Analysis, By Product,2019-2024
- 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
- 4.3.3.1. CBD Gummies
- 4.3.3.2. CBD Tinctures
- 4.3.3.3. Capsules & Softgels
- 4.3.3.4. Salves & Balms
- 4.3.3.5. Others
- 4.3.4. Market Attractiveness Analysis: Product
- 4.4. Global CBD Nutraceuticals Market Outlook: Form
- 4.4.1. Introduction / Key Findings
- 4.4.2. Historical Market Size (US$ Bn), By Form,2019-2024
- 4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
- 4.4.3.1. Ingestible
- 4.4.3.2. Topical
- 4.4.4. Market Attractiveness Analysis: Form
- 4.5. Global CBD Nutraceuticals Market Outlook: Application
- 4.5.1. Introduction / Key Findings
- 4.5.2. Historical Market Size (US$ Bn), By Application,2019-2024
- 4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 4.5.3.1. Pain Management
- 4.5.3.2. Sleep Support
- 4.5.3.3. Skin Health & Beauty
- 4.5.3.4. Workout Supplements
- 4.5.3.5. Others
- 4.5.4. Market Attractiveness Analysis: Application
- 4.6. Global CBD Nutraceuticals Market Outlook: Distribution Channel
- 4.6.1. Introduction / Key Findings
- 4.6.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel,2019-2024
- 4.6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
- 4.6.3.1. Hospital Pharmacies
- 4.6.3.2. Retail Pharmacies
- 4.6.3.3. Online Pharmacies
- 4.6.4. Market Attractiveness Analysis: Distribution Channel
5. Global CBD Nutraceuticals Market Outlook: Region
- 5.1. Key Highlights
- 5.2. Historical Market Size (US$ Bn) Analysis, By Region,2019-2024
- 5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. East Asia
- 5.3.4. South Asia and Oceania
- 5.3.5. Latin America
- 5.3.6. Middle East & Africa
- 5.4. Market Attractiveness Analysis: Region
6. North America CBD Nutraceuticals Market Outlook
- 6.1. Key Highlights
- 6.2. Historical Market Size (US$ Bn) Analysis, By Market,2019-2024
- 6.2.1. By Country
- 6.2.2. By Product
- 6.2.3. By Form
- 6.2.4. By Application
- 6.2.5. By Distribution Channel
- 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 6.3.1. U.S.
- 6.3.2. Canada
- 6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
- 6.4.1. CBD Gummies
- 6.4.2. CBD Tinctures
- 6.4.3. Capsules & Softgels
- 6.4.4. Salves & Balms
- 6.4.5. Others
- 6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
- 6.5.1. Ingestible
- 6.5.2. Topical
- 6.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 6.6.1. Pain Management
- 6.6.2. Sleep Support
- 6.6.3. Skin Health & Beauty
- 6.6.4. Workout Supplements
- 6.6.5. Others
- 6.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
- 6.7.1. Hospital Pharmacies
- 6.7.2. Retail Pharmacies
- 6.7.3. Online Pharmacies
- 6.8. Market Attractiveness Analysis
7. Europe CBD Nutraceuticals Market Outlook
- 7.1. Key Highlights
- 7.2. Historical Market Size (US$ Bn) Analysis, By Market,2019-2024
- 7.2.1. By Country
- 7.2.2. By Product
- 7.2.3. By Form
- 7.2.4. By Application
- 7.2.5. By Distribution Channel
- 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 7.3.1. Germany
- 7.3.2. France
- 7.3.3. U.K.
- 7.3.4. Italy
- 7.3.5. Spain
- 7.3.6. Russia
- 7.3.7. Turkey
- 7.3.8. Rest of Europe
- 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
- 7.4.1. CBD Gummies
- 7.4.2. CBD Tinctures
- 7.4.3. Capsules & Softgels
- 7.4.4. Salves & Balms
- 7.4.5. Others
- 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
- 7.5.1. Ingestible
- 7.5.2. Topical
- 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 7.6.1. Pain Management
- 7.6.2. Sleep Support
- 7.6.3. Skin Health & Beauty
- 7.6.4. Workout Supplements
- 7.6.5. Others
- 7.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
- 7.7.1. Hospital Pharmacies
- 7.7.2. Retail Pharmacies
- 7.7.3. Online Pharmacies
- 7.8. Market Attractiveness Analysis
8. East Asia CBD Nutraceuticals Market Outlook
- 8.1. Key Highlights
- 8.2. Historical Market Size (US$ Bn) Analysis, By Market,2019-2024
- 8.2.1. By Country
- 8.2.2. By Product
- 8.2.3. By Form
- 8.2.4. By Application
- 8.2.5. By Distribution Channel
- 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. South Korea
- 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
- 8.4.1. CBD Gummies
- 8.4.2. CBD Tinctures
- 8.4.3. Capsules & Softgels
- 8.4.4. Salves & Balms
- 8.4.5. Others
- 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
- 8.5.1. Ingestible
- 8.5.2. Topical
- 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 8.6.1. Pain Management
- 8.6.2. Sleep Support
- 8.6.3. Skin Health & Beauty
- 8.6.4. Workout Supplements
- 8.6.5. Others
- 8.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
- 8.7.1. Hospital Pharmacies
- 8.7.2. Retail Pharmacies
- 8.7.3. Online Pharmacies
- 8.8. Market Attractiveness Analysis
9. South Asia & Oceania CBD Nutraceuticals Market Outlook
- 9.1. Key Highlights
- 9.2. Historical Market Size (US$ Bn) Analysis, By Market,2019-2024
- 9.2.1. By Country
- 9.2.2. By Product
- 9.2.3. By Form
- 9.2.4. By Application
- 9.2.5. By Distribution Channel
- 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 9.3.1. India
- 9.3.2. Southeast Asia
- 9.3.3. ANZ
- 9.3.4. Rest of South Asia & Oceania
- 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
- 9.4.1. CBD Gummies
- 9.4.2. CBD Tinctures
- 9.4.3. Capsules & Softgels
- 9.4.4. Salves & Balms
- 9.4.5. Others
- 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
- 9.5.1. Ingestible
- 9.5.2. Topical
- 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 9.6.1. Pain Management
- 9.6.2. Sleep Support
- 9.6.3. Skin Health & Beauty
- 9.6.4. Workout Supplements
- 9.6.5. Others
- 9.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
- 9.7.1. Hospital Pharmacies
- 9.7.2. Retail Pharmacies
- 9.7.3. Online Pharmacies
- 9.8. Market Attractiveness Analysis
10. Latin America CBD Nutraceuticals Market Outlook
- 10.1. Key Highlights
- 10.2. Historical Market Size (US$ Bn) Analysis, By Market,2019-2024
- 10.2.1. By Country
- 10.2.2. By Product
- 10.2.3. By Form
- 10.2.4. By Application
- 10.2.5. By Distribution Channel
- 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 10.3.1. Brazil
- 10.3.2. Mexico
- 10.3.3. Rest of Latin America
- 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
- 10.4.1. CBD Gummies
- 10.4.2. CBD Tinctures
- 10.4.3. Capsules & Softgels
- 10.4.4. Salves & Balms
- 10.4.5. Others
- 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
- 10.5.1. Ingestible
- 10.5.2. Topical
- 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 10.6.1. Pain Management
- 10.6.2. Sleep Support
- 10.6.3. Skin Health & Beauty
- 10.6.4. Workout Supplements
- 10.6.5. Others
- 10.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
- 10.7.1. Hospital Pharmacies
- 10.7.2. Retail Pharmacies
- 10.7.3. Online Pharmacies
- 10.8. Market Attractiveness Analysis
11. Middle East & Africa CBD Nutraceuticals Market Outlook
- 11.1. Key Highlights
- 11.2. Historical Market Size (US$ Bn) Analysis, By Market,2019-2024
- 11.2.1. By Country
- 11.2.2. By Product
- 11.2.3. By Form
- 11.2.4. By Application
- 11.2.5. By Distribution Channel
- 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 11.3.1. GCC Countries
- 11.3.2. Egypt
- 11.3.3. South Africa
- 11.3.4. Northern Africa
- 11.3.5. Rest of Middle East & Africa
- 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
- 11.4.1. CBD Gummies
- 11.4.2. CBD Tinctures
- 11.4.3. Capsules & Softgels
- 11.4.4. Salves & Balms
- 11.4.5. Others
- 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
- 11.5.1. Ingestible
- 11.5.2. Topical
- 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 11.6.1. Pain Management
- 11.6.2. Sleep Support
- 11.6.3. Skin Health & Beauty
- 11.6.4. Workout Supplements
- 11.6.5. Others
- 11.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
- 11.7.1. Hospital Pharmacies
- 11.7.2. Retail Pharmacies
- 11.7.3. Online Pharmacies
- 11.8. Market Attractiveness Analysis
12. Competition Landscape
- 12.1. Market Share Analysis, 2025
- 12.2. Market Structure
- 12.2.1. Competition Intensity Mapping By Market
- 12.2.2. Competition Dashboard
- 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 12.3.1. GVB Biopharma
- 12.3.1.1. Overview
- 12.3.1.2. Segments and Products
- 12.3.1.3. Key Financials
- 12.3.1.4. Market Developments
- 12.3.1.5. Market Strategy
- 12.3.2. Brains
- 12.3.3. NOW
- 12.3.4. Dr. CBD Company Limited
- 12.3.5. dsm-firmenich
- 12.3.6. Charlotte's Web, Inc.
- 12.3.7. Elixinol
- 12.3.8. Medical Marijuana, Inc.
- 12.3.9. CV Sciences, Inc.
- 12.3.10. Irwin Naturals
- 12.3.11. Diamond CBD
- 12.3.12. Foria Wellness (Eden Partners LLC)
- 12.3.13. Medterra CBD
- 12.3.14. Green Roads
- 12.3.15. Isodiol International Inc
- 12.3.16. Garden of Life
- 12.3.17. Bluebird Botanicals (Gaia Botanicals, LLC)
- 12.3.18. Endoca
- 12.3.19. One Farm
- 12.3.20. Treadwell Farms
- 12.3.21. CBD Worx
- 12.3.22. USA Medical
- 12.3.23. NuLeaf Naturals, LLC
- 12.3.24. EarlyBird CBD
13. Appendix
- 13.1. Research Methodology
- 13.2. Research Assumptions
- 13.3. Acronyms and Abbreviations